Gara Jalqabaatti › Myeloma Baay’ee › Michigan › Grand Rapids
Qorannoo klinikaalii Myeloma Baay’ee Grand Rapids, MI keessatti
Qorannoo 8 Myeloma Baay’ee f Grand Rapids fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Namoota walitti qabaa jiraSadarkaa 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- Cancer And Hematology Centers of Western Michigan PC, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Cancer Research Consortium of West Michigan, Grand Rapids
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Namoota walitti qabaa jiraSadarkaa 1/2
- GSK Investigational Site, Grand Rapids
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Namoota walitti qabaa jiraSadarkaa 1
- START Midwest, Grand Rapids
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- START Midwest, Grand Rapids
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Namoota walitti qabaa jiraSadarkaa 3
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- START Midwest, Grand Rapids
Qorannoo Myeloma Baay’ee magaalota biroo keessatti
- New York City, NYQorannoo 60
- Boston, MAQorannoo 42
- Atlanta, GAQorannoo 41
- Houston, TXQorannoo 38
- Durham, NCQorannoo 37
- Nashville, TNQorannoo 32
- Denver, COQorannoo 27
- Rochester, MNQorannoo 24
- St. Louis, MOQorannoo 24
- Columbus, OHQorannoo 24
- Baldwin Park, CAQorannoo 23
- Chicago, ILQorannoo 22
Qorannoo biroo Grand Rapids keessatti
- Kansara Qara'a Non-Small CellQorannoo 44
- Kansarii ColorectalQorannoo 40
- Saree (Gosoota Hunda)Qorannoo 28
- Saree OljooQorannoo 25
- Kansarii OvariiQorannoo 24
- Kansara MetastatikiiQorannoo 22
- Kansarii ProstateQorannoo 19
- Kansa EndometiriyaaliiQorannoo 18
- Kanisa HarkaaQorannoo 18
- Kansarii PancreasQorannoo 18
- MelanomaQorannoo 17
- Kansaar Onnee Triple-NegativeQorannoo 15
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.